Literature DB >> 12706272

Placental transfer of rubella-specific IgG in fullterm and preterm newborns.

M Doroudchi1, A Samsami Dehaghani, K Emad, A Ghaderi.   

Abstract

OBJECTIVES: This study was undertaken to investigate placental transfer of anti-rubella IgG immunoglobulins in Iranian mothers.
METHODS: In total, 231 pregnant women and their paired infants enrolled in this study of which, 197 gave birth to fullterm and 26 gave birth to preterm infants. Rubella specific antibodies were detected by an in-house whole-virus ELISA assay in maternal and cord sera of 188 fullterm and 26 preterm infants.
RESULTS: A highly significant correlation was observed between anti-rubella IgG in newborns in total, in preterm and fullterm neonates with their paired mothers (P-values=0.0001, 0.002, 0.0001, respectively). A borderline significant difference was observed between mean anti-rubella IgG in fullterm and preterm neonates (P=0.04). Mean cord/maternal ratio of anti-rubella IgG was 0.83 which was surprisingly low. A significant lower anti-rubella IgG was observed in newborns born from mothers with blood group B+ than those born from mothers with blood groups A+ (P=0.04) and O+ (P=0.02), respectively. The same difference was observed between mean maternal anti-rubella IgG in those with blood groups B+ and A+ (P=0.04) and those with blood groups B+ and O+ (P=0.05). In addition, a low frequency of B+ blood group in high positive sera and a high frequency of this blood group among low positive and negative sera was detected.
CONCLUSIONS: Our data suggest that the main factors that influence the infants' rubella-specific IgG concentration are maternal concentration of this immunoglobulin, maternal blood group, and neonatal gestational age.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12706272     DOI: 10.1016/s0020-7292(02)00442-3

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  7 in total

1.  Maternal pneumococcal capsular IgG antibodies and transplacental transfer are low in South Asian HIV-infected mother-infant pairs.

Authors:  Amita Gupta; Jyoti S Mathad; Wei-Teng Yang; Harjot K Singh; Nikhil Gupte; Vidya Mave; Renu Bharadwaj; K Zaman; Eliza Roy; Robert C Bollinger; Ramesh Bhosale; Mark C Steinhoff
Journal:  Vaccine       Date:  2014-01-30       Impact factor: 3.641

Review 2.  Maternal Immunization: Nature Meets Nurture.

Authors:  Anja Saso; Beate Kampmann
Journal:  Front Microbiol       Date:  2020-07-24       Impact factor: 5.640

Review 3.  IgG placental transfer in healthy and pathological pregnancies.

Authors:  Patricia Palmeira; Camila Quinello; Ana Lúcia Silveira-Lessa; Cláudia Augusta Zago; Magda Carneiro-Sampaio
Journal:  Clin Dev Immunol       Date:  2011-10-01

Review 4.  Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies.

Authors:  Stefan Niewiesk
Journal:  Front Immunol       Date:  2014-09-16       Impact factor: 7.561

5.  Rubella antibodies in cord blood sera in Portugal: association with maternal age and vaccination status.

Authors:  J Frade; C Nunes; J R Mesquita; M São José Nascimento; G Gonçalves
Journal:  Epidemiol Infect       Date:  2018-02-20       Impact factor: 4.434

6.  The Potential Role of Nonhuman Primate Models to Better Comprehend Early Life Immunity and Maternal Antibody Transfer.

Authors:  Julie Sartoretti; Christiane S Eberhardt
Journal:  Vaccines (Basel)       Date:  2021-03-24

7.  Update on Transplacental Transfer of IgG Subclasses: Impact of Maternal and Fetal Factors.

Authors:  Toby Clements; Thomas F Rice; George Vamvakas; Sara Barnett; Megan Barnes; Beverly Donaldson; Christine E Jones; Beate Kampmann; Beth Holder
Journal:  Front Immunol       Date:  2020-09-11       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.